267 related articles for article (PubMed ID: 19416196)
1. Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system.
Sutton SW; Shelton J; Smith C; Williams J; Yun S; Motley T; Kuei C; Bonaventure P; Gundlach A; Liu C; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():242-9. PubMed ID: 19416196
[TBL] [Abstract][Full Text] [Related]
2. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
3. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
4. Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain.
Smith CM; Shen PJ; Banerjee A; Bonaventure P; Ma S; Bathgate RA; Sutton SW; Gundlach AL
J Comp Neurol; 2010 Oct; 518(19):4016-45. PubMed ID: 20737598
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological activation of RXFP3 is not orexigenic in C57BL/6J mice.
Smith CM; Hosken IT; Downer NL; Chua BE; Hossain MA; Wade JD; Gundlach AL
Ital J Anat Embryol; 2013; 118(1 Suppl):52-5. PubMed ID: 24640572
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3.
Haugaard-Kedström LM; Shabanpoor F; Hossain MA; Clark RJ; Ryan PJ; Craik DJ; Gundlach AL; Wade JD; Bathgate RA; Rosengren KJ
J Am Chem Soc; 2011 Apr; 133(13):4965-74. PubMed ID: 21384867
[TBL] [Abstract][Full Text] [Related]
7. Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus.
Ganella DE; Callander GE; Ma S; Bye CR; Gundlach AL; Bathgate RA
Gene Ther; 2013 Jul; 20(7):703-16. PubMed ID: 23135160
[TBL] [Abstract][Full Text] [Related]
8. Central injection of relaxin-3 receptor (RXFP3) antagonist peptides reduces motivated food seeking and consumption in C57BL/6J mice.
Smith CM; Chua BE; Zhang C; Walker AW; Haidar M; Hawkes D; Shabanpoor F; Hossain MA; Wade JD; Rosengren KJ; Gundlach AL
Behav Brain Res; 2014 Jul; 268():117-26. PubMed ID: 24681162
[TBL] [Abstract][Full Text] [Related]
9. Viral-mediated delivery of an RXFP3 agonist into brain promotes arousal in mice.
Smith CM; Blasiak A; Ganella DE; Chua BE; Layfield SL; Bathgate RA; Gundlach AL
Ital J Anat Embryol; 2013; 118(1 Suppl):42-6. PubMed ID: 24640570
[TBL] [Abstract][Full Text] [Related]
10. Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology.
Kristensson L; Mayer G; Ploj K; Wetterlund M; Arlbrandt S; Björquist A; Wissing BM; Castaldo M; Larsson N
Eur J Pharmacol; 2015 Jan; 747():123-31. PubMed ID: 25496752
[TBL] [Abstract][Full Text] [Related]
11. Relaxin-3 mRNA levels in nucleus incertus correlate with alcohol and sucrose intake in rats.
Ryan PJ; Krstew EV; Sarwar M; Gundlach AL; Lawrence AJ
Drug Alcohol Depend; 2014 Jul; 140():8-16. PubMed ID: 24837581
[TBL] [Abstract][Full Text] [Related]
12. Localization of relaxin-3 in brain of Macaca fascicularis: identification of a nucleus incertus in primate.
Ma S; Sang Q; Lanciego JL; Gundlach AL
J Comp Neurol; 2009 Dec; 517(6):856-72. PubMed ID: 19844992
[TBL] [Abstract][Full Text] [Related]
13. Relaxin family peptides and receptors in mammalian brain.
Gundlach AL; Ma S; Sang Q; Shen PJ; Piccenna L; Sedaghat K; Smith CM; Bathgate RA; Lawrence AJ; Tregear GW; Wade JD; Finkelstein DI; Bonaventure P; Liu C; Lovenberg TW; Sutton SW
Ann N Y Acad Sci; 2009 Apr; 1160():226-35. PubMed ID: 19416194
[TBL] [Abstract][Full Text] [Related]
14. Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat.
Ryan PJ; Büchler E; Shabanpoor F; Hossain MA; Wade JD; Lawrence AJ; Gundlach AL
Behav Brain Res; 2013 May; 244():142-51. PubMed ID: 23380674
[TBL] [Abstract][Full Text] [Related]
15. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3).
Kocan M; Sarwar M; Hossain MA; Wade JD; Summers RJ
Br J Pharmacol; 2014 Jun; 171(11):2827-41. PubMed ID: 24641548
[TBL] [Abstract][Full Text] [Related]
16. Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications.
Ganella DE; Ryan PJ; Bathgate RA; Gundlach AL
Behav Pharmacol; 2012 Sep; 23(5-6):516-25. PubMed ID: 22854307
[TBL] [Abstract][Full Text] [Related]
17. Addition of a carboxy-terminal green fluorescent protein does not alter the binding and signaling properties of relaxin family Peptide receptor 3.
van der Westhuizen ET; Wade JD; Sexton PM; Summers RJ
Ann N Y Acad Sci; 2009 Apr; 1160():105-7. PubMed ID: 19416168
[TBL] [Abstract][Full Text] [Related]
18. Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress.
Tanaka M; Iijima N; Miyamoto Y; Fukusumi S; Itoh Y; Ozawa H; Ibata Y
Eur J Neurosci; 2005 Mar; 21(6):1659-70. PubMed ID: 15845093
[TBL] [Abstract][Full Text] [Related]
19. Central relaxin-3 receptor (RXFP3) activation reduces elevated, but not basal, anxiety-like behaviour in C57BL/6J mice.
Zhang C; Chua BE; Yang A; Shabanpoor F; Hossain MA; Wade JD; Rosengren KJ; Smith CM; Gundlach AL
Behav Brain Res; 2015 Oct; 292():125-32. PubMed ID: 26057358
[TBL] [Abstract][Full Text] [Related]
20. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
